Screener
Zymeworks ZYME Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Zymeworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001937653-26-000047
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Operating lease liabilities | (1,788) | (1,632) |
| Deferred revenue | (588) | (21,777) |
| Income taxes payable | (38) | (27) |
| Net cash (used in) provided by operating activities | (77,666) | 8,666 |
| Cash flows from investing activities: | ||
| Purchases of marketable securities | (62,532) | (104,179) |
| Proceeds from marketable securities | 149,781 | 126,328 |
| Acquisition of property and equipment | (216) | (530) |
Item 1. Financial Statements
FAQ
- What is Zymeworks's operating cash flow?
- Zymeworks (ZYME) reported operating cash flow of -$31.95M in Q2 2026.
- How has Zymeworks's operating cash flow changed year-over-year?
- Zymeworks's operating cash flow decreased by 364.6% year-over-year, from $12.07M to -$31.95M.
- What is the long-term trend for Zymeworks's operating cash flow?
- Over 2 years (2022 to 2025), Zymeworks's operating cash flow has grown at a -52.1% compound annual growth rate (CAGR), from $144.11M to -$33.01M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Zymeworks's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude